Altimmune (ALT) Enterprise Value (2017 - 2026)
Altimmune's Enterprise Value was $264.88 million in Q2 2026, up 81.3% from $146.1 million a year earlier and up 281.1% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Enterprise Value (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Altimmune's Enterprise Value was -$551.02 million through Jun 30, 2026; for FY2025, it was $44.56 million, down 88.6% from FY2024.
- Enterprise Value has now declined for three consecutive years, with a five-year compound annual growth rate of -9.5% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $389.73 million in FY2024 (-2.9%), $401.17 million in FY2023 (-35.8%), $624.42 million in FY2022 (+237.2%) and $185.17 million in FY2021 (+152.9%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value since Q4 2024.
- Compared with a year earlier, Enterprise Value was higher in 1 of the last seven quarters, with an average decline of 34.1%.
- The best year-over-year quarter for Enterprise Value over five years was Q4 2022 (growth of 237.2%); the worst was Q2 2023 (a decline of 92.8%).
- Per Business Quant data, ALT's Enterprise Value in the three quarters before Q2 2026 was $69.5 million (Q1 2026), $44.56 million (Q4 2025) and $149.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Altimmune | 575.64 Mn | 575.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 264.88 Mn |
| Mar 31, 2026 | 69.50 Mn |
| Dec 31, 2025 | 44.56 Mn |
| Sep 30, 2025 | 149.59 Mn |
| Jun 30, 2025 | 146.10 Mn |
| Mar 31, 2025 | 239.26 Mn |
| Dec 31, 2024 | 389.73 Mn |
| Sep 30, 2024 | 297.28 Mn |
| Jun 30, 2024 | 307.51 Mn |
| Mar 31, 2024 | 539.69 Mn |
| Dec 31, 2023 | 401.17 Mn |
| Sep 30, 2023 | -3.39 Mn |
| Jun 30, 2023 | 25.89 Mn |
| Mar 31, 2023 | 42.23 Mn |
| Dec 31, 2022 | 624.42 Mn |
| Sep 30, 2022 | 425.93 Mn |
| Jun 30, 2022 | 357.76 Mn |
| Mar 31, 2022 | 83.23 Mn |
| Dec 31, 2021 | 185.17 Mn |
| Sep 30, 2021 | 249.12 Mn |
API Access
Altimmune Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();